Moderna, Inc. (NASDAQ:MRNA) is an American biotechnology company that discovers, develops, and sells messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno ...

In fact, all but one of them beat the S&P last year: NVDA data by YCharts. Nvidia stock is likely to be a top performer again in 2025 as the company ramps up shipments of its new Blackwell ...

the ETF's compound annual return has accelerated to 20.2% over the last 10 years. That crushes the 13.7% annualized gains of the S&P over the same period, and the difference is staggering when ...